Jay Venkatesan's Trading History
| SERSerina Therapeutics | Jun 22, 2026 | Director | Informative Buy | 1.05K | $450.65K | |
| ELTXElicio Therapeutics | Nov 29, 2024 | Director | Informative Buy | 500.00 | $303.30K | |
| ALPNAlpine Immune Sciences | Sep 21, 2021 | ― | Informative Sell | 3.76M | $186.88M | |
| XCURExicure | Jul 08, 2020 | Director | Uninformative Buy | 19.37K | $679.01K | |
| CASCCascadian Therapeutics | Sep 25, 2014 | ― | Uninformative Buy | 500.00K | $43.49M | |
| IOVAIovance Biotherapeutics | ― | Director | ― | $0.00 |
You May Also Like
Jay Venkatesan insider profile FAQ
What is the percentage of profitable transactions made by Jay Venkatesan?
The percentage of profitable transactions made by Jay Venkatesan is 33%.
What is the average return per transaction made by Jay Venkatesan?
The average return per transaction made by Jay Venkatesan is -21.80%.
What stocks does Jay Venkatesan hold?
Jay Venkatesan holds: ELTX, CASC, ALPN, SER, XCUR, IOVA stocks.
What was Jay Venkatesan’s latest transaction?
Jay Venkatesan’s latest transaction was an Informative Buy of $1.05K.
What was Jay Venkatesan's most profitable transaction?
Jay Venkatesan’s most profitable transaction was an Informative Buy of ELTX stock on November 29, 2024. The return on the trade was 83.80%.
What is Jay Venkatesan's role in Elicio Therapeutics?
Jay Venkatesan's role in Elicio Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.